Item 2.02 Results of Operations and Financial Condition.
On January 11, 2022, Nephros, Inc. (the "Company") issued a press release in
which it disclosed its preliminary fourth quarter and fiscal year 2021 financial
results. A copy of this press release is furnished herewith as Exhibit 99.1.
Pursuant to the rules and regulations of the Securities and Exchange Commission,
such exhibit and the information set forth therein and in this Item 2.02 have
been furnished and shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to liability under that section nor shall they be deemed incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such filing regardless of any general incorporation language.
Item 7.01 Regulation FD Disclosure.
On January 13, 2022, the Company distributed a letter to its stockholders
providing an update on the Company's business. A copy of this letter is filed
herewith as Exhibit 99.2.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Nephros, Inc. Press Release, dated January 11, 2022.
99.2 Nephros, Inc. Letter to Stockholders, dated January 13, 2022.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
© Edgar Online, source Glimpses